Vertex Pharmaceuticals (NASDAQ:VRTX), a global biotechnology company with a market capitalization of $119.1 billion known for its transformative cystic fibrosis (CF) treatments, finds itself at a ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

Vertex Pharmaceuticals could soon capture $10 billion in sales of non-opioid painkillers, an analyst said Friday as Vertex stock jumped.

The Aerospace Corporation (Aerospace), a national nonprofit operating the only federally funded research and development ...

Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...

PRNewswire New Delhi [India] January 24 Attentiveai a leading AI-based SaaS startup today announced the successful close of its Series A2 funding round completing a 12M raise in Series A in two tranch ...

Despite the economic uncertainties, healthcare analytics companies have demonstrated strong resilience throughout 2024. The global healthcare analytics industry market size is estimated to grow from ...

Copyright 2025 The Associated Press. All Rights Reserved. Minnesota forward Dawson Garcia (3) celebrates with teammates after a game-winning 3-point shot at the ...

Garcia’s 3-pointer from the near edge of the center-court logo beat the overtime buzzer to give Minnesota an 84-81 victory over No. 20 Michigan on Thursday night. Garcia, whose two free throws ...

As we gear up for this playoff matchup, we're going to dive into the depths of these teams and see which of them has the edge at every position. Chiefs: Patrick Mahomes Texans: C.J. Stroud This ...

Pearce emerged as one of the top edge rushers in college football over the past two seasons while helping the Volunteers take significant defensive strides. The former four-star prospect is ...

In a report released today, Gena Wang from Barclays maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a price target of $418.00. The company’s shares closed ...